Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bulk naproxen

This article was originally published in The Tan Sheet

Executive Summary

AlliedSignal acquires second largest manufacturer of bulk naproxen, Lugano, Switzerland-based Pharmaceutical Fine Chemicals, the chemical company's third purchase in the area of pharmaceutical active ingredient production in the past three years. PFC had 1997 sales of $110 mil. AlliedSignal is acquiring the firm from a management and investment group headed by Donaldson, Lufkin & Jenrette's Merchant Banking Group. PFC was founded in 1992 from the combination of two Italian chemical producers, Alfa Chemicals and ICFI. The start-up was led by PFC's current CEO, Pietro Stefanutti. The management buy-in was financed through the British investment group, 3i, which later contributed to the expansion of PFC by acting as the investment banker for the 11 bil. Lira ($62.7 mil.) purchase of a Roche/Syntex plant in the Bahamas, bringing naproxen production into PFC's line. AlliedSignal's recent acquisition activity and the six-year ownership/investment history of PFC indicate an active market for pharmaceutical production services...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088482

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel